Factors affecting prostate cancer detection through asymptomatic prostate-specific antigen testing in primary care in England: evidence from the 2018 National Cancer Diagnosis Audit
One in five patients with prostate cancer in England are diagnosed after asymptomatic PSA testing in primary care, with large variation in asymptomatic PSA detection between practices.
Authors
- Greg Rubin (ORCID: https://orcid.org/0000-0002-4967-0297)
- Gary Abel (ORCID: https://orcid.org/0000-0003-2231-5161)
- Sean McPhail
- Ruth Swann (ORCID: https://orcid.org/0000-0003-3789-4979)
- Georgios Lyratzopoulos (ORCID: https://orcid.org/0000-0002-2873-7421)
- Samuel WD Merriel (ORCID: https://orcid.org/0000-0003-2919-9087)
- Nadine Zakkak (ORCID: https://orcid.org/0000-0003-4155-7756)
- Nurunnahar Akter (ORCID: https://orcid.org/0000-0002-8802-9080)
Institutions
- University of Liverpool (GB)
- University of Exeter (GB)
- Manchester Academic Health Science Centre (GB)
- Cancer Research UK (GB)
- University of Manchester (GB)
- London Cancer (GB)
- Cancer Research Horizons (GB)
- NHS Digital (GB)
- Primary Health Care (QA)
- The Behaviouralist (United Kingdom) (GB)
- National Cancer Registration Service (GB)
- University College London (GB)
- University of Newcastle Australia (AU)
- Newcastle University (GB)
Publication Details
- Journal
- British Journal of General Practice
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3399/bjgp.2024.0376
- Citations
- 4
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.68